We also evaluated a broader range of outcome indicators, encompassing not only FBG, glycosylated hemoglobin, and insulin resistance but also psychological outcomes (depression, anxiety, and somatization) and anthropometric measures (BMI, WHR, and weight), which were underrepresented in prior reviews. The gene discussed is INS; the disease is depressive symptom measurement.